loadpatents
name:-0.016808986663818
name:-0.011809110641479
name:-0.0012710094451904
Delos Santos; Efren Guillermo Patent Filings

Delos Santos; Efren Guillermo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Delos Santos; Efren Guillermo.The latest application filed is for "triazine compounds as pi3 kinase and mtor inhibitors".

Company Profile
0.11.13
  • Delos Santos; Efren Guillermo - Nanuet NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 10,022,381 - Venkatesan , et al. July 17, 2
2018-07-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20170224696 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2017-08-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20170119778 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2017-05-04
Triazine compounds as PI3 kinase and MTOR inhibitors
Grant 9,174,963 - Venkatesan , et al. November 3, 2
2015-11-03
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20150011752 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2015-01-08
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,859,542 - Venkatesan , et al. October 14, 2
2014-10-14
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20140248239 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2014-09-04
Triazine compounds as P13 kinase and MTOR inhibitors
Grant 8,748,421 - Venkatesan , et al. June 10, 2
2014-06-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20130315865 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2013-11-28
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,575,159 - Venkatesan , et al. November 5, 2
2013-11-05
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,445,486 - Venkatesan , et al. May 21, 2
2013-05-21
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20130109670 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2013-05-02
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,217,036 - Venkatesan , et al. July 10, 2
2012-07-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20110312955 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2011-12-22
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20090304692 - Venkatesan; Aranapakam Mudumbai ;   et al.
2009-12-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20090291079 - Venkatesan; Aranapakam Mudumbai ;   et al.
2009-11-26
1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
App 20090192176 - Zask; Arie ;   et al.
2009-07-30
3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
App 20090181963 - Dehnhardt; Christoph Martin ;   et al.
2009-07-16
Imidazolopyrimidine Analogs And Their Use As Pi3 Kinase And Mtor Inhibitors
App 20080233127 - Bursavich; Matthew Gregory ;   et al.
2008-09-25
Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors
Grant 7,282,496 - Sandanayaka , et al. October 16, 2
2007-10-16
Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
App 20030130238 - Sandanayaka, Vincent Premaratna ;   et al.
2003-07-10
2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids
Grant 6,544,984 - Albright , et al. April 8, 2
2003-04-08
Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
Grant 5,889,001 - Albright , et al. March 30, 1
1999-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed